New Leaf Biopharma Fund Overview – Investment Track Record Summary

New Leaf Biopharma Fund Overview – Investment Track Record Summary The passage is a promotional summary of a biopharmaceutical investment fund, listing past deals and exits. It contains no allegations, financial flow details, or connections to high‑profile public officials or controversial actions, offering no actionable investigative leads. Key insights: Describes New Leaf's network of senior pharma executives, scientists, and investors.; Lists several portfolio companies and exit multiples (e.g., Pearl Therapeutics sold to AstraZeneca).; Mentions restructuring and recapitalization activities in private and public biotech firms.